164 related articles for article (PubMed ID: 36514506)
1. Persistent epigenetic alterations in transcription factors after a sustained virological response in hepatocellular carcinoma.
Sugimachi K; Araki H; Saito H; Masuda T; Miura F; Inoue K; Shimagaki T; Mano Y; Iguchi T; Morita M; Toh Y; Yoshizumi T; Ito T; Mimori K
JGH Open; 2022 Dec; 6(12):854-863. PubMed ID: 36514506
[TBL] [Abstract][Full Text] [Related]
2. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Hamdane N; Jühling F; Crouchet E; El Saghire H; Thumann C; Oudot MA; Bandiera S; Saviano A; Ponsolles C; Roca Suarez AA; Li S; Fujiwara N; Ono A; Davidson I; Bardeesy N; Schmidl C; Bock C; Schuster C; Lupberger J; Habersetzer F; Doffoël M; Piardi T; Sommacale D; Imamura M; Uchida T; Ohdan H; Aikata H; Chayama K; Boldanova T; Pessaux P; Fuchs BC; Hoshida Y; Zeisel MB; Duong FHT; Baumert TF
Gastroenterology; 2019 Jun; 156(8):2313-2329.e7. PubMed ID: 30836093
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic transcriptomic profile is sustained in the liver after the eradication of the hepatitis C virus.
Takeda H; Takai A; Iguchi E; Mishima M; Arasawa S; Kumagai K; Eso Y; Shimizu T; Takahashi K; Ueda Y; Taura K; Hatano E; Iijima H; Aoyagi H; Aizaki H; Marusawa H; Wakita T; Seno H
Carcinogenesis; 2021 May; 42(5):672-684. PubMed ID: 33617626
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression in hepatocellular carcinoma after the eradication of chronic hepatitis virus C infection using interferon therapy.
Tamori A; Murakami Y; Kubo S; Itami S; Uchida-Kobayashi S; Morikawa H; Enomoto M; Takemura S; Tanahashi T; Taguchi YH; Kawada N
Hepatol Res; 2016 Mar; 46(3):E26-35. PubMed ID: 25788219
[TBL] [Abstract][Full Text] [Related]
6. Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection.
Nirei K; Kanda T; Nakamura H; Matsuoka S; Takayama T; Sugitani M; Moriyama M
Int J Med Sci; 2018; 15(5):466-474. PubMed ID: 29559835
[No Abstract] [Full Text] [Related]
7. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection.
Hayashi T; Tamori A; Nishikawa M; Morikawa H; Enomoto M; Sakaguchi H; Habu D; Kawada N; Kubo S; Nishiguchi S; Shiomi S
Liver Int; 2009 Jan; 29(1):126-32. PubMed ID: 18492017
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response.
Toyoda H; Tada T; Yasuda S; Mizuno K; Ito T; Kumada T
Clin Infect Dis; 2020 Mar; 70(6):1208-1214. PubMed ID: 31056696
[TBL] [Abstract][Full Text] [Related]
9. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
11. Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.
Toyoda H; Tada T; Takaguchi K; Senoh T; Shimada N; Hiraoka A; Michitaka K; Ishikawa T; Kumada T
J Viral Hepat; 2017 Jun; 24(6):472-476. PubMed ID: 27983762
[TBL] [Abstract][Full Text] [Related]
12. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics.
Rinaldi L; Nevola R; Franci G; Perrella A; Corvino G; Marrone A; Berretta M; Morone MV; Galdiero M; Giordano M; Adinolfi LE; Sasso FC
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466400
[TBL] [Abstract][Full Text] [Related]
13. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
[TBL] [Abstract][Full Text] [Related]
14. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.
Seko Y; Moriguchi M; Takahashi A; Yamaguchi K; Umemura A; Okuda K; Kataoka S; Unozawa H; Kobayashi K; Ogasawara S; Sato R; Tsuchiya S; Watanabe S; Morimoto N; Iwai K; Aramaki T; Kato N; Itoh Y
J Gastroenterol; 2022 Feb; 57(2):90-98. PubMed ID: 35031857
[TBL] [Abstract][Full Text] [Related]
16. Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation.
Ryu T; Takami Y; Wada Y; Tateishi M; Matsushima H; Yoshitomi M; Mikagi K; Saitsu H
Hepatol Int; 2018 Mar; 12(2):149-157. PubMed ID: 29488056
[TBL] [Abstract][Full Text] [Related]
17. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N
PLoS One; 2018; 13(3):e0194163. PubMed ID: 29534101
[TBL] [Abstract][Full Text] [Related]
18. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
Audureau E; Carrat F; Layese R; Cagnot C; Asselah T; Guyader D; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Chazouillères O; Mallat A; Grangé JD; Attali P; d'Alteroche L; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Pol S; Nahon P;
J Hepatol; 2020 Dec; 73(6):1434-1445. PubMed ID: 32615276
[TBL] [Abstract][Full Text] [Related]
19. Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C.
Chun HS; Kim BK; Park JY; Kim DY; Ahn SH; Han KH; Lee CH; Lee YB; Cho EJ; Yu SJ; Kim YJ; Yoon JH; Lee JH; Kim SU
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):378-385. PubMed ID: 32011388
[TBL] [Abstract][Full Text] [Related]
20. Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma.
Goncharova IA; Zarubin AA; Babushkina NP; Koroleva IA; Nazarenko MS
Vavilovskii Zhurnal Genet Selektsii; 2023 Mar; 27(1):72-82. PubMed ID: 36923478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]